Clinical Trials Browser

Interventional × Thrombocytopenia × romiplostim × Clear all

NCT04478123 2024-02-14

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Phase 2 Completed

62 enrolled 7 charts

Classical hematologyLymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Thrombocytopenia

NCT01676961 2018-10-15

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Phase 2 Terminated

5 enrolled 4 charts

Classical hematologyPlasma cell

Multiple Myeloma, Thrombocytopenia

NCT02227576 2018-04-25

PLATUM

Phase 2 Terminated

CNSClassical hematology

Glioblastoma, Thrombocytopenia

NCT01444417 2017-02-09

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Phase 3 Completed

62 enrolled 16 charts 1 FDA

Classical hematology

Purpura, Thrombocytopenic, Thrombocytopenia, Purpura, Thrombocytopenic, Idiopathic

NCT00147225 2014-05-08

AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin

Phase 1/2 Completed

55 enrolled 11 charts

Classical hematology

Thrombocytopenia

NCT00413283 2013-10-24

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

63 enrolled 15 charts

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Thrombocytopenia

NCT00283439 2011-06-20

A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma

Phase 1/2 Completed

39 enrolled 13 charts

Classical hematologyLymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Thrombocytopenia